CORRECTION article

Front. Genet., 16 January 2023

Sec. Cancer Genetics and Oncogenomics

Volume 13 - 2022 | https://doi.org/10.3389/fgene.2022.1117731

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

  • 1. Cancer Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China

  • 2. Department of Neurosurgery, The Affiliated Huzhou Hospital, Zhejiang University School of Medicine (Huzhou Central Hospital), Huzhou, China

  • 3. Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China

In the published article, there was an error regarding the Affiliation for “Xiaoxing Xiong2,3.” As well as having affiliations 2,3, he should also have “1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

TMCO3, ICB, diagnostics, immune infiltrates, LIHC

Citation

Hu X, Zhu H, Feng S, Wang C, Ye Y and Xiong X (2023) Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma. Front. Genet. 13:1117731. doi: 10.3389/fgene.2022.1117731

Received

06 December 2022

Accepted

08 December 2022

Published

16 January 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Yingze Ye, ; Xiaoxing Xiong,

† These authors have contributed equally to this work

This article was submitted to Cancer Genetics and Oncogenomics, a section of the journal Frontiers in Genetics

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics